{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T17:19:37Z","timestamp":1793380777494,"version":"4.5.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2018,1,24]],"date-time":"2018-01-24T00:00:00Z","timestamp":1516752000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2018,1,24]],"date-time":"2018-01-24T00:00:00Z","timestamp":1516752000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Gestational trophoblastic disease (GTD) encompasses a range of trophoblast-derived disorders. The most common type of GTD is hydatidiform mole (HM). Some of HMs can further develop into malignant gestational trophoblastic neoplasia (GTN). Aberrant expression of microRNA (miRNA) is widely reported to be involved in the initiation and progression of cancers. MiRNA expression profile also has been proved to be the useful signature for diagnosis, staging, prognosis, and response to chemotherapy. Till now, the profile of miRNA in the progression of GTD has not been determined. In this study, a total of 34 GTN and 60 complete HMs (CHM) trophoblastic tissues were collected. By miRNA array screening and qRT-PCR validating, six miRNAs, including miR-370-3p, -371a-5p, -518a-3p, -519d-3p, -520a-3p, and -934, were identified to be differentially expressed in GTN vs. CHM. Functional analyses further proved that miR-371a-5p and miR-518a-3p promoted proliferation, migration, and invasion of choriocarcinoma cells. Moreover, we demonstrated that miR-371a-5p was negatively related to protein levels of its predictive target genes <jats:italic>BCCIP, SOX2<\/jats:italic>,<jats:italic> and BNIP3L<\/jats:italic>, while miR-518a-3p was negatively related to <jats:italic>MST1<\/jats:italic> and <jats:italic>EFNA4<\/jats:italic>. For the first time, we proved that miR-371a-5p and miR-518a-3p directly targeted to 3\u2032-UTR regions of <jats:italic>BCCIP<\/jats:italic> and <jats:italic>MST1<\/jats:italic>, respectively. Additionally, we found that miR-371a-5p and miR-518a-3p regulated diverse pathways related to tumorigenesis and metastasis in choriocarcinoma cells. The results presented here may offer new clues to the progression of GTD and may provide diagnostic biomarkers for GTN.<\/jats:p>","DOI":"10.1038\/s41419-017-0108-2","type":"journal-article","created":{"date-parts":[[2018,1,24]],"date-time":"2018-01-24T15:26:58Z","timestamp":1516807618000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["Identification of microRNA signature in the progression of gestational trophoblastic disease"],"prefix":"10.1038","volume":"9","author":[{"given":"Jiu-Ru","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-Wei","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ya-Xin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mei","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-Bin","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui-Juan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,1,24]]},"reference":[{"key":"108_CR1","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1111\/j.1048-891X.2004.014236.x","volume":"14","author":"HYS Ngan","year":"2004","unstructured":"Ngan, H. Y. S. The practicability of FIGO 2000 staging for gestational trophoblastic neoplasia. Int. J. Gynecol. Cancer 14, 202\u2013205 (2004).","journal-title":"Int. J. Gynecol. Cancer"},{"key":"108_CR2","volume-title":"WHO Classification of Tumours of Female Reproductive Organ","year":"2014","unstructured":"Kurman, R. J., Carcangiu, M. L., Herrington, C. S. & Young, R. H. (eds) WHO Classification of Tumours of Female Reproductive Organ 4th edn (IARC Press, Lyon, France, 2014).","edition":"4th edn"},{"key":"108_CR3","doi-asserted-by":"crossref","unstructured":"Szulman, A. E. in Gestational Trophoblastic Disease (eds Szulman, A. E. & Buchsbaum, H. J.) 37\u201344 (Springer New York, New York, USA, 1987).","DOI":"10.1007\/978-1-4612-4698-5_4"},{"key":"108_CR4","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1016\/S1521-6934(03)00049-X","volume":"17","author":"SJ Steigrad","year":"2003","unstructured":"Steigrad, S. J. Epidemiology of gestational trophoblastic diseases. Best Pract. Res. Clin. Obstet. Gynaecol. 17, 837\u2013847 (2003).","journal-title":"Best Pract. Res. Clin. Obstet. Gynaecol."},{"key":"108_CR5","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1007\/s13669-013-0071-6","volume":"3","author":"SF Ngu","year":"2014","unstructured":"Ngu, S.-F. & Chan, K. K. L. Management of chemoresistant and quiescent gestational trophoblastic disease. Curr. Obstet. Gynecol. Rep. 3, 84\u201390 (2014).","journal-title":"Curr. Obstet. Gynecol. Rep."},{"key":"108_CR6","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1093\/humrep\/deq052","volume":"25","author":"B Baasanjav","year":"2010","unstructured":"Baasanjav, B. et al. The risk of post-molar gestational trophoblastic neoplasia is higher in heterozygous than in homozygous complete hydatidiform moles. Hum. Reprod. 25, 1183\u20131191 (2010).","journal-title":"Hum. Reprod."},{"key":"108_CR7","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/j.ygyno.2015.05.041","volume":"138","author":"NL Neubauer","year":"2015","unstructured":"Neubauer, N. L., Strohl, A. E., Schink, J. C. & Lurain, J. R. Fatal gestational trophoblastic neoplasia: an analysis of treatment failures at the Brewer Trophoblastic Disease Center from 1979\u20132012 compared to 1962\u20131978. Gynecol. Oncol. 138, 339\u2013342 (2015).","journal-title":"Gynecol. Oncol."},{"key":"108_CR8","doi-asserted-by":"publisher","first-page":"1785","DOI":"10.1126\/science.1151651","volume":"319","author":"O Hobert","year":"2008","unstructured":"Hobert, O. Gene regulation by transcription factors and microRNAs. Science 319, 1785\u20131786 (2008).","journal-title":"Science"},{"key":"108_CR9","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1038\/nrc1997","volume":"6","author":"GA Calin","year":"2006","unstructured":"Calin, G. A. & Croce, C. M. MicroRNA signatures in human cancers. Nat. Rev. Cancer 6, 857\u2013866 (2006).","journal-title":"Nat. Rev. Cancer"},{"key":"108_CR10","doi-asserted-by":"publisher","first-page":"7065","DOI":"10.1158\/0008-5472.CAN-05-1783","volume":"65","author":"MV Iorio","year":"2005","unstructured":"Iorio, M. V. et al. MicroRNA gene expression deregulation in human breast cancer. Cancer Res. 65, 7065\u20137070 (2005).","journal-title":"Cancer Res."},{"key":"108_CR11","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1002\/ijc.22394","volume":"120","author":"EJ Lee","year":"2007","unstructured":"Lee, E. J. et al. Expression profiling identifies microRNA signature in pancreatic cancer. Int. J. Cancer 120, 1046\u20131054 (2007).","journal-title":"Int. J. Cancer"},{"key":"108_CR12","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.ccr.2006.01.025","volume":"9","author":"N Yanaihara","year":"2006","unstructured":"Yanaihara, N. et al. Unique microRNA molecular profiles in lung cancer diagnosis and prognosis. Cancer Cell 9, 189\u2013198 (2006).","journal-title":"Cancer Cell"},{"key":"108_CR13","doi-asserted-by":"publisher","first-page":"2405","DOI":"10.1007\/s00204-016-1815-7","volume":"90","author":"K Piletic","year":"2016","unstructured":"Piletic, K. & Kunej, T. MicroRNA epigenetic signatures in human disease. Arch. Toxicol. 90, 2405\u20132419 (2016).","journal-title":"Arch. Toxicol."},{"key":"108_CR14","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1002\/emmm.201100209","volume":"4","author":"MV Iorio","year":"2012","unstructured":"Iorio, M. V. & Croce, C. M. MicroRNA dysregulation in cancer: diagnostics, monitoring and therapeutics. A comprehensive review. EMBO Mol. Med. 4, 143\u2013159 (2012).","journal-title":"EMBO Mol. Med."},{"key":"108_CR15","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.1093\/carcin\/bgs140","volume":"33","author":"MV Iorio","year":"2012","unstructured":"Iorio, M. V. & Croce, C. M. microRNA involvement in human cancer. Carcinogenesis 33, 1126\u20131133 (2012).","journal-title":"Carcinogenesis"},{"key":"108_CR16","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/1755-8166-5-40","volume":"5","author":"V Rippe","year":"2012","unstructured":"Rippe, V. et al. Activation of the two microRNA clusters C19MC and miR-371-3 does not play prominent role in thyroid cancer. Mol. Cytogenet. 5, 40 (2012).","journal-title":"Mol. Cytogenet."},{"key":"108_CR17","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1097\/IGC.0b013e3182574439","volume":"22","author":"Q Na","year":"2012","unstructured":"Na, Q., Wang, D. & Song, W. Underexpression of 4 placenta-associated microRNAs in complete hydatidiform moles. Int. J. Gynecol. Cancer 22, 1075\u20131080 (2012).","journal-title":"Int. J. Gynecol. Cancer"},{"key":"108_CR18","doi-asserted-by":"publisher","first-page":"1410","DOI":"10.1373\/clinchem.2013.206391","volume":"59","author":"Y Hasegawa","year":"2013","unstructured":"Hasegawa, Y., Miura, K., Furuya, K., Yoshiura K-i & Masuzaki, H. Identification of complete hydatidiform mole pregnancy\u2013associated microRNAs in plasma. Clin. Chem. 59, 1410\u20131412 (2013).","journal-title":"Clin. Chem."},{"key":"108_CR19","doi-asserted-by":"publisher","first-page":"1767","DOI":"10.1373\/clinchem.2010.147660","volume":"56","author":"K Miura","year":"2010","unstructured":"Miura, K. et al. Identification of pregnancy-associated microRNAs in maternal plasma. Clin. Chem. 56, 1767\u20131771 (2010).","journal-title":"Clin. Chem."},{"key":"108_CR20","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.canlet.2009.10.005","volume":"291","author":"A Chao","year":"2010","unstructured":"Chao, A. et al. Decreased expression of microRNA-199b increases protein levels of SET (protein phosphatase 2A inhibitor) in human choriocarcinoma. Cancer Lett. 291, 99\u2013107 (2010).","journal-title":"Cancer Lett."},{"key":"108_CR21","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1097\/IGC.0000000000000861","volume":"27","author":"YX Wang","year":"2017","unstructured":"Wang, Y.-X., Zhao, J.-R., Xu, Y.-Y., Wu, W.-B. & Zhang, H.-J. MiR-21 is overexpressed in hydatidiform mole tissues and promotes proliferation, migration, and invasion in choriocarcinoma cells. Int. J. Gynecol. Cancer 27, 364\u2013374 (2017).","journal-title":"Int. J. Gynecol. Cancer"},{"key":"108_CR22","doi-asserted-by":"publisher","first-page":"3124","DOI":"10.1242\/jcs.096412","volume":"125","author":"L Luo","year":"2012","unstructured":"Luo, L. et al. MicroRNA-378a-5p promotes trophoblast cell survival, migration and invasion by targeting Nodal. J. Cell Sci. 125, 3124\u20133132 (2012).","journal-title":"J. Cell Sci."},{"key":"108_CR23","doi-asserted-by":"publisher","first-page":"a023036","DOI":"10.1101\/cshperspect.a023036","volume":"5","author":"Y Sadovsky","year":"2015","unstructured":"Sadovsky, Y., Mouillet, J.-F., Ouyang, Y., Bayer, A. & Coyne, C. B. The function of trophomiRs and other microRNAs in the human placenta. Cold Spring Harb. Perspect. Med. 5, a023036 (2015).","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"108_CR24","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1309\/AJCPOE11KEYZCJHT","volume":"135","author":"MJ Murray","year":"2011","unstructured":"Murray, M. J. et al. Identification of microRNAs from the miR-371~373 and miR-302 clusters as potential serum biomarkers of malignant germ cell tumors. Am. J. Clin. Pathol. 135, 119\u2013125 (2011).","journal-title":"Am. J. Clin. Pathol."},{"key":"108_CR25","doi-asserted-by":"publisher","first-page":"5647","DOI":"10.3892\/mmr.2015.4221","volume":"12","author":"Q Zhang","year":"2015","unstructured":"Zhang, Q. et al. Analysis of the differential expression of circulating microRNAs during the progression of hepatic fibrosis in patients with chronic hepatitis B virus infection. Mol. Med. Rep. 12, 5647\u20135654 (2015).","journal-title":"Mol. Med. Rep."},{"key":"108_CR26","doi-asserted-by":"publisher","first-page":"4525","DOI":"10.1007\/s13277-015-3097-8","volume":"36","author":"Y Shen","year":"2015","unstructured":"Shen, Y. et al. Identifying microRNA-mRNA regulatory network in gemcitabine-resistant cells derived from human pancreatic cancer cells. Tumour Biol. 36, 4525\u20134534 (2015).","journal-title":"Tumour Biol."},{"key":"108_CR27","doi-asserted-by":"publisher","first-page":"e84486","DOI":"10.1371\/journal.pone.0084486","volume":"8","author":"G Li","year":"2013","unstructured":"Li, G. et al. Genome-wide analyses of radioresistance-associated miRNA expression profile in nasopharyngeal carcinoma using next generation deep sequencing. PLoS ONE 8, e84486 (2013).","journal-title":"PLoS ONE"},{"key":"108_CR28","doi-asserted-by":"publisher","first-page":"e9485","DOI":"10.1371\/journal.pone.0009485","volume":"5","author":"V Rippe","year":"2010","unstructured":"Rippe, V. et al. The two stem cell microRNA gene clusters C19MC and miR-371-3 are activated by specific chromosomal rearrangements in a subgroup of thyroid adenomas. PLoS ONE 5, e9485 (2010).","journal-title":"PLoS ONE"},{"key":"108_CR29","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1002\/path.2586","volume":"219","author":"R Baffa","year":"2009","unstructured":"Baffa, R. et al. MicroRNA expression profiling of human metastatic cancers identifies cancer gene targets. J. Pathol. 219, 214\u2013221 (2009).","journal-title":"J. Pathol."},{"key":"108_CR30","doi-asserted-by":"publisher","DOI":"10.1186\/1476-4598-10-52","volume":"10","author":"M Port","year":"2011","unstructured":"Port, M. et al. MicroRNA expression in cisplatin resistant germ cell tumor cell lines. Mol. Cancer 10, 52 (2011).","journal-title":"Mol. Cancer"},{"key":"108_CR31","doi-asserted-by":"publisher","first-page":"1266","DOI":"10.3892\/ijmm.2015.2145","volume":"35","author":"LL Qu","year":"2015","unstructured":"Qu, L. L., He, L., Zhao, X. & Xu, W. Downregulation of miR-518a-3p activates the NIK-dependent NF-kappaB pathway in colorectal cancer. Int. J. Mol. Med. 35, 1266\u20131272 (2015).","journal-title":"Int. J. Mol. Med."},{"key":"108_CR32","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.biopha.2015.07.019","volume":"75","author":"P Xu","year":"2015","unstructured":"Xu, P. et al. Identification and characterization of microRNAs expressed in human breast cancer chemo-resistant MCF-7\/Adr cells by Solexa deep-sequencing technology. Biomed. Pharmacother. 75, 173\u2013178 (2015).","journal-title":"Biomed. Pharmacother."},{"key":"108_CR33","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2015.280","volume":"6","author":"M d\u2019Avenia","year":"2015","unstructured":"d\u2019Avenia, M. et al. A novel miR-371a-5p-mediated pathway, leading to BAG3 upregulation in cardiomyocytes in response to epinephrine, is lost in Takotsubo cardiomyopathy. Cell Death Dis. 6, e1948 (2015).","journal-title":"Cell Death Dis."},{"key":"108_CR34","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1038\/nature07242","volume":"455","author":"D Baek","year":"2008","unstructured":"Baek, D. et al. The impact of microRNAs on protein output. Nature 455, 64\u201371 (2008).","journal-title":"Nature"},{"key":"108_CR35","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/S0378-1119(02)01098-3","volume":"302","author":"X Meng","year":"2003","unstructured":"Meng, X., Liu, J. & Shen, Z. Genomic structure of the human BCCIP gene and its expression in cancer. Gene 302, 139\u2013146 (2003).","journal-title":"Gene"},{"key":"108_CR36","doi-asserted-by":"publisher","first-page":"1570","DOI":"10.1074\/jbc.M607520200","volume":"282","author":"X Meng","year":"2007","unstructured":"Meng, X., Yue, J., Liu, Z. & Shen, Z. Abrogation of the transactivation activity of p53 by BCCIP down-regulation. J. Biol. Chem. 282, 1570\u20131576 (2007).","journal-title":"J. Biol. Chem."},{"key":"108_CR37","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1016\/j.ccr.2004.10.012","volume":"6","author":"P Fei","year":"2004","unstructured":"Fei, P. et al. Bnip3L is induced by p53 under hypoxia, and its knockdown promotes tumor growth. Cancer Cell 6, 597\u2013609 (2004).","journal-title":"Cancer Cell"},{"key":"108_CR38","doi-asserted-by":"publisher","first-page":"6253","DOI":"10.1038\/sj.onc.1210460","volume":"26","author":"X Meng","year":"2007","unstructured":"Meng, X., Fan, J. & Shen, Z. Roles of BCCIP in chromosome stability and cytokinesis. Oncogene 26, 6253\u20136260 (2007).","journal-title":"Oncogene"},{"key":"108_CR39","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1177\/1933719108322433","volume":"15","author":"ASM Li","year":"2008","unstructured":"Li, A. S. M. et al. Hypermethylation of SOX2 gene in hydatidiform mole and choriocarcinoma. Reprod. Sci. 15, 735\u2013744 (2008).","journal-title":"Reprod. Sci."},{"key":"108_CR40","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1038\/modpathol.3800740","volume":"20","author":"P Minoo","year":"2007","unstructured":"Minoo, P. et al. Prognostic significance of mammalian sterile20-like kinase 1 in colorectal cancer. Modern Pathol. 20, 331\u2013338 (2007).","journal-title":"Modern Pathol."},{"key":"108_CR41","doi-asserted-by":"publisher","first-page":"E1312","DOI":"10.1073\/pnas.1110428108","volume":"108","author":"D Zhou","year":"2011","unstructured":"Zhou, D. et al. Mst1 and Mst2 protein kinases restrain intestinal stem cell proliferation and colonic tumorigenesis by inhibition of Yes-associated protein (Yap) overabundance. Proc. Natl Acad. Sci. USA 108, E1312\u2013E1320 (2011).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"108_CR42","doi-asserted-by":"publisher","first-page":"1897","DOI":"10.4161\/cc.10.12.15826","volume":"10","author":"H Cornils","year":"2011","unstructured":"Cornils, H., Kohler, R. S., Hergovich, A. & Hemmings, B. A. Downstream of human NDR kinases: impacting on c-myc and p21 protein stability to control cell cycle progression. Cell Cycle 10, 1897\u20131904 (2011).","journal-title":"Cell Cycle"},{"key":"108_CR43","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1016\/j.cellsig.2007.12.019","volume":"20","author":"P Ling","year":"2008","unstructured":"Ling, P., Lu, T. J., Yuan, C. J. & Lai, M. D. Biosignaling of mammalian Ste20-related kinases. Cell Signal 20, 1237\u20131247 (2008).","journal-title":"Cell Signal"},{"key":"108_CR44","first-page":"22","volume":"24","author":"YX Wang","year":"2015","unstructured":"Wang, Y. X., Zhang, H. J., Liu, Y., Wu, W. B. & Xu, Y. Y. The activation of PI3K\/PKB signaling in pathogenesis of gestational trophoblastic disease. Prog. Obstet. Gynecol. 24, 22\u201329 (2015).","journal-title":"Prog. Obstet. Gynecol."},{"key":"108_CR45","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1097\/IGC.0b013e3182849e36","volume":"23","author":"H Fujiwara","year":"2013","unstructured":"Fujiwara, H. et al. Eph-Ephrin A system regulates human choriocarcinoma\u2013derived JEG-3 cell invasion. Int. J. Gynecol. Cancer 23, 576\u2013582 (2013).","journal-title":"Int. J. Gynecol. Cancer"},{"key":"108_CR46","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1016\/j.placenta.2014.07.012","volume":"35","author":"W Wu","year":"2014","unstructured":"Wu, W. et al. Dysregulated activation of c-Src in gestational trophoblastic disease contributes to its aggressive progression. Placenta 35, 824\u2013830 (2014).","journal-title":"Placenta"},{"key":"108_CR47","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1038\/gt.2011.79","volume":"18","author":"AG Bader","year":"2011","unstructured":"Bader, A. G., Brown, D., Stoudemire, J. & Lammers, P. Developing therapeutic microRNAs for cancer. Gene Ther. 18, 1121\u20131126 (2011).","journal-title":"Gene Ther."},{"key":"108_CR48","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1038\/nmeth.3317","volume":"12","author":"D Kim","year":"2015","unstructured":"Kim, D., Langmead, B. & Salzberg, S. L. HISAT: a fast spliced aligner with low memory requirements. Nat. Methods 12, 357\u2013360 (2015).","journal-title":"Nat. Methods"}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-017-0108-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-017-0108-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-017-0108-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,20]],"date-time":"2022-12-20T11:34:57Z","timestamp":1671536097000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-017-0108-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1,24]]},"references-count":48,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2018,2]]}},"alternative-id":["108"],"URL":"https:\/\/doi.org\/10.1038\/s41419-017-0108-2","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,1,24]]},"assertion":[{"value":"13 July 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 October 2017","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 October 2017","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 January 2018","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"94"}}